After treatment with BMSCs combined with JSSQ of liver cirrhosis in rats, the improvement of liver function, hepatic fibrosis, pathological tissue, and other related indicators was better than the combined G-CSF transplantation group (P<0.01). Here, CSF3 is linked to cirrhosis of liver.